Victory Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$362K Sell
15,030
-1,058
-7% -$27.7K 0.04% 255
2026
Q1
$452K Buy
16,088
+1,964
+14% +$52.3K 0.06% 201
2025
Q4
$352K Buy
14,124
+3,084
+28% +$77.8K 0.04% 219
2025
Q3
$284K Buy
11,040
+2,727
+33% +$67.3K 0.04% 197
2025
Q2
$202K Buy
+8,313
New +$194K 0.03% 222

Other funds holding PFE

Victory Financial Group's PFE Position: Q2 2026 in Review

Victory Financial Group reduced its Pfizer (PFE) stake by 6.6% in Q2 2026, selling an estimated $27.7K and leaving 15,030 shares worth $362K. The position accounts for 0.04% of the portfolio, ranked #255.

Victory Financial Group first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $452K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Victory Financial Group held 15,030 shares of Pfizer worth $362K as of Q2 2026.
  • Victory Financial Group sold 1,058 Pfizer shares in Q2 2026, an estimated $27.7K.
  • Pfizer made up 0.04% of Victory Financial Group's portfolio in Q2 2026, its #255 holding.
  • Victory Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Victory Financial Group's Pfizer position peaked at $452K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Victory Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.